non-linear regression analysis (variable slope model with a four-parameter dose–response curve) in graphpad prism 7 software Search Results


90
GraphPad Software Inc prism 7.0 software
Prism 7.0 Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-linear+regression+analysis+%28variable+slope+model+with+a+four-parameter+dose%E2%80%93response+curve%29+in+graphpad+prism+7+software/pmc06217908-178-10-9?v=GraphPad+Software+Inc
Average 90 stars, based on 1 article reviews
prism 7.0 software - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc graphpad prism7 software
Impact of 1 and 2 compounds on BT474 breast cancer cells. ( A ) To assess whether 1 and 2 could trigger cytotoxic effects on living cells, BT474 cells were treated with serial dilutions of 1 and 2 (or sterile DMSO). After three days, live cells were detected by standard MTT assay, highlighting the appearance of cytotoxic effects above 75 μM for compound 1 . Compound 2 did not show cytotoxic effects even at 250 μM. ***p < 0.001; ****p < 0.0001. ( B ) 1 and 2 compounds inhibit cell proliferation of BT474 and ( C ) SKBR3 breast cancer cell lines. Cells were treated with different concentration of the 1 and 2 and proliferation was assayed three days later by performing MTT assay. Results were fitted with four-parameter dose-response curve using GraphPad <t>Prism7</t> software. ( D ) EC50 values for 1 and 2 in BT474 and SKBR3 breast cancer cell lines are represented as histogram with 95% confidence intervals. ( E ) SKBR3 cells were treated with Trastuzumab (25 μg/ml) either alone or in combination with compound 1 or 2 at the indicated doses. After three days, live cells were detected by standard MTT assay. Data are represented as mean ± SD. *p < 0.05, **p < 0.01. ( D ) SKH100 Trastuzumab-resistant cells were treated with Trastuzumab (100 μg/ml) either alone or in combination with compound 1 or 2 at the indicated doses. After three days, live cells were detected by standard MTT assay. Data are represented as mean ± SD. *p < 0.05, **p < 0.01.
Graphpad Prism7 Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-linear+regression+analysis+%28variable+slope+model+with+a+four-parameter+dose%E2%80%93response+curve%29+in+graphpad+prism+7+software/pmc06395809-177-9-8?v=GraphPad+Software+Inc
Average 90 stars, based on 1 article reviews
graphpad prism7 software - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc variable slope model graphpad prism 7.02
Impact of 1 and 2 compounds on BT474 breast cancer cells. ( A ) To assess whether 1 and 2 could trigger cytotoxic effects on living cells, BT474 cells were treated with serial dilutions of 1 and 2 (or sterile DMSO). After three days, live cells were detected by standard MTT assay, highlighting the appearance of cytotoxic effects above 75 μM for compound 1 . Compound 2 did not show cytotoxic effects even at 250 μM. ***p < 0.001; ****p < 0.0001. ( B ) 1 and 2 compounds inhibit cell proliferation of BT474 and ( C ) SKBR3 breast cancer cell lines. Cells were treated with different concentration of the 1 and 2 and proliferation was assayed three days later by performing MTT assay. Results were fitted with four-parameter dose-response curve using GraphPad <t>Prism7</t> software. ( D ) EC50 values for 1 and 2 in BT474 and SKBR3 breast cancer cell lines are represented as histogram with 95% confidence intervals. ( E ) SKBR3 cells were treated with Trastuzumab (25 μg/ml) either alone or in combination with compound 1 or 2 at the indicated doses. After three days, live cells were detected by standard MTT assay. Data are represented as mean ± SD. *p < 0.05, **p < 0.01. ( D ) SKH100 Trastuzumab-resistant cells were treated with Trastuzumab (100 μg/ml) either alone or in combination with compound 1 or 2 at the indicated doses. After three days, live cells were detected by standard MTT assay. Data are represented as mean ± SD. *p < 0.05, **p < 0.01.
Variable Slope Model Graphpad Prism 7.02, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-linear+regression+analysis+%28variable+slope+model+with+a+four-parameter+dose%E2%80%93response+curve%29+in+graphpad+prism+7+software/pm29185769-74-14-13?v=GraphPad+Software+Inc
Average 90 stars, based on 1 article reviews
variable slope model graphpad prism 7.02 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc four-parameter fit of a sigmoidal dose–response curve
Impact of 1 and 2 compounds on BT474 breast cancer cells. ( A ) To assess whether 1 and 2 could trigger cytotoxic effects on living cells, BT474 cells were treated with serial dilutions of 1 and 2 (or sterile DMSO). After three days, live cells were detected by standard MTT assay, highlighting the appearance of cytotoxic effects above 75 μM for compound 1 . Compound 2 did not show cytotoxic effects even at 250 μM. ***p < 0.001; ****p < 0.0001. ( B ) 1 and 2 compounds inhibit cell proliferation of BT474 and ( C ) SKBR3 breast cancer cell lines. Cells were treated with different concentration of the 1 and 2 and proliferation was assayed three days later by performing MTT assay. Results were fitted with four-parameter dose-response curve using GraphPad <t>Prism7</t> software. ( D ) EC50 values for 1 and 2 in BT474 and SKBR3 breast cancer cell lines are represented as histogram with 95% confidence intervals. ( E ) SKBR3 cells were treated with Trastuzumab (25 μg/ml) either alone or in combination with compound 1 or 2 at the indicated doses. After three days, live cells were detected by standard MTT assay. Data are represented as mean ± SD. *p < 0.05, **p < 0.01. ( D ) SKH100 Trastuzumab-resistant cells were treated with Trastuzumab (100 μg/ml) either alone or in combination with compound 1 or 2 at the indicated doses. After three days, live cells were detected by standard MTT assay. Data are represented as mean ± SD. *p < 0.05, **p < 0.01.
Four Parameter Fit Of A Sigmoidal Dose–Response Curve, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-linear+regression+analysis+%28variable+slope+model+with+a+four-parameter+dose%E2%80%93response+curve%29+in+graphpad+prism+7+software/pmc06002484-109-13-16?v=GraphPad+Software+Inc
Average 90 stars, based on 1 article reviews
four-parameter fit of a sigmoidal dose–response curve - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc non-linear regression analysis
Impact of 1 and 2 compounds on BT474 breast cancer cells. ( A ) To assess whether 1 and 2 could trigger cytotoxic effects on living cells, BT474 cells were treated with serial dilutions of 1 and 2 (or sterile DMSO). After three days, live cells were detected by standard MTT assay, highlighting the appearance of cytotoxic effects above 75 μM for compound 1 . Compound 2 did not show cytotoxic effects even at 250 μM. ***p < 0.001; ****p < 0.0001. ( B ) 1 and 2 compounds inhibit cell proliferation of BT474 and ( C ) SKBR3 breast cancer cell lines. Cells were treated with different concentration of the 1 and 2 and proliferation was assayed three days later by performing MTT assay. Results were fitted with four-parameter dose-response curve using GraphPad <t>Prism7</t> software. ( D ) EC50 values for 1 and 2 in BT474 and SKBR3 breast cancer cell lines are represented as histogram with 95% confidence intervals. ( E ) SKBR3 cells were treated with Trastuzumab (25 μg/ml) either alone or in combination with compound 1 or 2 at the indicated doses. After three days, live cells were detected by standard MTT assay. Data are represented as mean ± SD. *p < 0.05, **p < 0.01. ( D ) SKH100 Trastuzumab-resistant cells were treated with Trastuzumab (100 μg/ml) either alone or in combination with compound 1 or 2 at the indicated doses. After three days, live cells were detected by standard MTT assay. Data are represented as mean ± SD. *p < 0.05, **p < 0.01.
Non Linear Regression Analysis, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-linear+regression+analysis+%28variable+slope+model+with+a+four-parameter+dose%E2%80%93response+curve%29+in+graphpad+prism+7+software/pmc11028140-105-5-17?v=GraphPad+Software+Inc
Average 90 stars, based on 1 article reviews
non-linear regression analysis - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc four-parameter variable slope-fitting method graphpad prism 7.0
Impact of 1 and 2 compounds on BT474 breast cancer cells. ( A ) To assess whether 1 and 2 could trigger cytotoxic effects on living cells, BT474 cells were treated with serial dilutions of 1 and 2 (or sterile DMSO). After three days, live cells were detected by standard MTT assay, highlighting the appearance of cytotoxic effects above 75 μM for compound 1 . Compound 2 did not show cytotoxic effects even at 250 μM. ***p < 0.001; ****p < 0.0001. ( B ) 1 and 2 compounds inhibit cell proliferation of BT474 and ( C ) SKBR3 breast cancer cell lines. Cells were treated with different concentration of the 1 and 2 and proliferation was assayed three days later by performing MTT assay. Results were fitted with four-parameter dose-response curve using GraphPad <t>Prism7</t> software. ( D ) EC50 values for 1 and 2 in BT474 and SKBR3 breast cancer cell lines are represented as histogram with 95% confidence intervals. ( E ) SKBR3 cells were treated with Trastuzumab (25 μg/ml) either alone or in combination with compound 1 or 2 at the indicated doses. After three days, live cells were detected by standard MTT assay. Data are represented as mean ± SD. *p < 0.05, **p < 0.01. ( D ) SKH100 Trastuzumab-resistant cells were treated with Trastuzumab (100 μg/ml) either alone or in combination with compound 1 or 2 at the indicated doses. After three days, live cells were detected by standard MTT assay. Data are represented as mean ± SD. *p < 0.05, **p < 0.01.
Four Parameter Variable Slope Fitting Method Graphpad Prism 7.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-linear+regression+analysis+%28variable+slope+model+with+a+four-parameter+dose%E2%80%93response+curve%29+in+graphpad+prism+7+software/pmc09468961-106-6-10?v=GraphPad+Software+Inc
Average 90 stars, based on 1 article reviews
four-parameter variable slope-fitting method graphpad prism 7.0 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc 4pl
Summary of cytotoxicity of typical A. sydowii metabolites, dust storm/shellfish-associated mycotoxins, okadaic acid algal toxins on HT-29 and SH-SY5Y cells after 24 h exposure. Inhibitory concentration 50% (IC 50 ) values and 95% confidence interval (CI) were calculated from four replicates using the <t> four-parameter logistic model </t> <t> (4PL) </t> model.
4pl, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-linear+regression+analysis+%28variable+slope+model+with+a+four-parameter+dose%E2%80%93response+curve%29+in+graphpad+prism+7+software/pmc06315785-163-9-21?v=GraphPad+Software+Inc
Average 90 stars, based on 1 article reviews
4pl - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc graphpad prism 7
Summary of cytotoxicity of typical A. sydowii metabolites, dust storm/shellfish-associated mycotoxins, okadaic acid algal toxins on HT-29 and SH-SY5Y cells after 24 h exposure. Inhibitory concentration 50% (IC 50 ) values and 95% confidence interval (CI) were calculated from four replicates using the <t> four-parameter logistic model </t> <t> (4PL) </t> model.
Graphpad Prism 7, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-linear+regression+analysis+%28variable+slope+model+with+a+four-parameter+dose%E2%80%93response+curve%29+in+graphpad+prism+7+software/pm29937766-102-27-27?v=GraphPad+Software+Inc
Average 90 stars, based on 1 article reviews
graphpad prism 7 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc nonlinear regression curve fit, dose-response − stimulation − log(agonist) versus response − variable slope (four parameter)
Summary of cytotoxicity of typical A. sydowii metabolites, dust storm/shellfish-associated mycotoxins, okadaic acid algal toxins on HT-29 and SH-SY5Y cells after 24 h exposure. Inhibitory concentration 50% (IC 50 ) values and 95% confidence interval (CI) were calculated from four replicates using the <t> four-parameter logistic model </t> <t> (4PL) </t> model.
Nonlinear Regression Curve Fit, Dose Response − Stimulation − Log(agonist) Versus Response − Variable Slope (Four Parameter), supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-linear+regression+analysis+%28variable+slope+model+with+a+four-parameter+dose%E2%80%93response+curve%29+in+graphpad+prism+7+software/pmc05729612-112-11-27?v=GraphPad+Software+Inc
Average 90 stars, based on 1 article reviews
nonlinear regression curve fit, dose-response − stimulation − log(agonist) versus response − variable slope (four parameter) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc variable slope four-parameter logistic equation
Summary of cytotoxicity of typical A. sydowii metabolites, dust storm/shellfish-associated mycotoxins, okadaic acid algal toxins on HT-29 and SH-SY5Y cells after 24 h exposure. Inhibitory concentration 50% (IC 50 ) values and 95% confidence interval (CI) were calculated from four replicates using the <t> four-parameter logistic model </t> <t> (4PL) </t> model.
Variable Slope Four Parameter Logistic Equation, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-linear+regression+analysis+%28variable+slope+model+with+a+four-parameter+dose%E2%80%93response+curve%29+in+graphpad+prism+7+software/pm31134152-82-11-25?v=GraphPad+Software+Inc
Average 90 stars, based on 1 article reviews
variable slope four-parameter logistic equation - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc nonlinear regression least square method in the variable slope model graphpad prism 7.0
Summary of cytotoxicity of typical A. sydowii metabolites, dust storm/shellfish-associated mycotoxins, okadaic acid algal toxins on HT-29 and SH-SY5Y cells after 24 h exposure. Inhibitory concentration 50% (IC 50 ) values and 95% confidence interval (CI) were calculated from four replicates using the <t> four-parameter logistic model </t> <t> (4PL) </t> model.
Nonlinear Regression Least Square Method In The Variable Slope Model Graphpad Prism 7.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-linear+regression+analysis+%28variable+slope+model+with+a+four-parameter+dose%E2%80%93response+curve%29+in+graphpad+prism+7+software/pmc06390661-236-14-17?v=GraphPad+Software+Inc
Average 90 stars, based on 1 article reviews
nonlinear regression least square method in the variable slope model graphpad prism 7.0 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc four-parameter non-linear regression analysis software
Summary of cytotoxicity of typical A. sydowii metabolites, dust storm/shellfish-associated mycotoxins, okadaic acid algal toxins on HT-29 and SH-SY5Y cells after 24 h exposure. Inhibitory concentration 50% (IC 50 ) values and 95% confidence interval (CI) were calculated from four replicates using the <t> four-parameter logistic model </t> <t> (4PL) </t> model.
Four Parameter Non Linear Regression Analysis Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-linear+regression+analysis+%28variable+slope+model+with+a+four-parameter+dose%E2%80%93response+curve%29+in+graphpad+prism+7+software/pmc06992935-162-5-9?v=GraphPad+Software+Inc
Average 90 stars, based on 1 article reviews
four-parameter non-linear regression analysis software - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Impact of 1 and 2 compounds on BT474 breast cancer cells. ( A ) To assess whether 1 and 2 could trigger cytotoxic effects on living cells, BT474 cells were treated with serial dilutions of 1 and 2 (or sterile DMSO). After three days, live cells were detected by standard MTT assay, highlighting the appearance of cytotoxic effects above 75 μM for compound 1 . Compound 2 did not show cytotoxic effects even at 250 μM. ***p < 0.001; ****p < 0.0001. ( B ) 1 and 2 compounds inhibit cell proliferation of BT474 and ( C ) SKBR3 breast cancer cell lines. Cells were treated with different concentration of the 1 and 2 and proliferation was assayed three days later by performing MTT assay. Results were fitted with four-parameter dose-response curve using GraphPad Prism7 software. ( D ) EC50 values for 1 and 2 in BT474 and SKBR3 breast cancer cell lines are represented as histogram with 95% confidence intervals. ( E ) SKBR3 cells were treated with Trastuzumab (25 μg/ml) either alone or in combination with compound 1 or 2 at the indicated doses. After three days, live cells were detected by standard MTT assay. Data are represented as mean ± SD. *p < 0.05, **p < 0.01. ( D ) SKH100 Trastuzumab-resistant cells were treated with Trastuzumab (100 μg/ml) either alone or in combination with compound 1 or 2 at the indicated doses. After three days, live cells were detected by standard MTT assay. Data are represented as mean ± SD. *p < 0.05, **p < 0.01.

Journal: Scientific Reports

Article Title: Modeling ErbB2-p130Cas interaction to design new potential anticancer agents

doi: 10.1038/s41598-019-39510-w

Figure Lengend Snippet: Impact of 1 and 2 compounds on BT474 breast cancer cells. ( A ) To assess whether 1 and 2 could trigger cytotoxic effects on living cells, BT474 cells were treated with serial dilutions of 1 and 2 (or sterile DMSO). After three days, live cells were detected by standard MTT assay, highlighting the appearance of cytotoxic effects above 75 μM for compound 1 . Compound 2 did not show cytotoxic effects even at 250 μM. ***p < 0.001; ****p < 0.0001. ( B ) 1 and 2 compounds inhibit cell proliferation of BT474 and ( C ) SKBR3 breast cancer cell lines. Cells were treated with different concentration of the 1 and 2 and proliferation was assayed three days later by performing MTT assay. Results were fitted with four-parameter dose-response curve using GraphPad Prism7 software. ( D ) EC50 values for 1 and 2 in BT474 and SKBR3 breast cancer cell lines are represented as histogram with 95% confidence intervals. ( E ) SKBR3 cells were treated with Trastuzumab (25 μg/ml) either alone or in combination with compound 1 or 2 at the indicated doses. After three days, live cells were detected by standard MTT assay. Data are represented as mean ± SD. *p < 0.05, **p < 0.01. ( D ) SKH100 Trastuzumab-resistant cells were treated with Trastuzumab (100 μg/ml) either alone or in combination with compound 1 or 2 at the indicated doses. After three days, live cells were detected by standard MTT assay. Data are represented as mean ± SD. *p < 0.05, **p < 0.01.

Article Snippet: Results were fitted with four-parameter dose-response curve using GraphPad Prism7 software. ( D ) EC50 values for 1 and 2 in BT474 and SKBR3 breast cancer cell lines are represented as histogram with 95% confidence intervals. ( E ) SKBR3 cells were treated with Trastuzumab (25 μg/ml) either alone or in combination with compound 1 or 2 at the indicated doses.

Techniques: MTT Assay, Concentration Assay, Software

Summary of cytotoxicity of typical A. sydowii metabolites, dust storm/shellfish-associated mycotoxins, okadaic acid algal toxins on HT-29 and SH-SY5Y cells after 24 h exposure. Inhibitory concentration 50% (IC 50 ) values and 95% confidence interval (CI) were calculated from four replicates using the  four-parameter logistic model   (4PL)  model.

Journal: Toxins

Article Title: Combined Cytotoxicity of the Phycotoxin Okadaic Acid and Mycotoxins on Intestinal and Neuroblastoma Human Cell Models

doi: 10.3390/toxins10120526

Figure Lengend Snippet: Summary of cytotoxicity of typical A. sydowii metabolites, dust storm/shellfish-associated mycotoxins, okadaic acid algal toxins on HT-29 and SH-SY5Y cells after 24 h exposure. Inhibitory concentration 50% (IC 50 ) values and 95% confidence interval (CI) were calculated from four replicates using the four-parameter logistic model (4PL) model.

Article Snippet: Briefly, the dose response curves were fitted with the four-parameter logistic model (4PL), and 95% asymptotic confidence intervals were calculated using GraphPad Prism 7.

Techniques: Concentration Assay